Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?

J Clin Oncol. 2010 Aug 1;28(22):3552-4. doi: 10.1200/JCO.2009.27.8184. Epub 2010 Jul 6.
No abstract available

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Carcinoma, Lobular / drug therapy*
  • Estrogens / therapeutic use
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Receptor, ErbB-2 / metabolism*
  • Receptors, Estrogen / metabolism*

Substances

  • Estrogens
  • Receptors, Estrogen
  • Receptor, ErbB-2